ASML: New Pricing Power Makes The 28x Multiple A Bargain

ASML provided Q4 revenue guidance of €14.2–€15.2B, above the article author's €13B threshold and supporting the author's Strong Buy rating. Upgrade-kit sales amid chip shortages are benefiting margins, while the company accelerated its Q3 buyback to €4.1B. Higher prices for EUV machines beginning in 2027, with full effect in 2028, could further lift EPS and margins.

Analysis

The near-term signal is the quality and durability of demand, not the headline guide: verify order intake, backlog conversion, shipment timing, and whether upgrade-kit strength offsets any softness in new systems. The stated guide comparison is against the author’s threshold, not independently established market expectations, so it does not by itself establish an earnings surprise. Likewise, buybacks support per-share results only if repurchases are not merely offsetting dilution; they are not proof of stronger end demand.

Over 1–3 months, revisions to bookings and customer capex plans are the key catalysts. Over 6–18 months, higher EUV pricing could improve economics, but the 2027–28 timing makes it a valuation-supporting option rather than a near-term EPS driver; realization depends on contract terms, product mix, and customers’ ability and willingness to absorb higher prices. ASML’s concentrated exposure to a small set of advanced-chip buyers leaves it vulnerable to delayed fab investment, export restrictions, and shifts in customer technology roadmaps. The contrarian risk is that investors capitalize distant pricing benefits too early while near-term system demand or margins disappoint.

Key Decisions for Investors

• Construct or retain a measured long ASML position, preferably adding on a pullback rather than chasing the bullish narrative. The upside case is continued order conversion plus eventual pricing realization; the downside is near-term estimate compression if bookings, shipment cadence, or margins weaken.
• For the next earnings update, track net bookings and backlog conversion, system-versus-upgrade mix, gross-margin guidance, and buyback pace relative to dilution. Treat strength in buybacks without improving operating indicators as a weaker signal.
• Falsify the constructive thesis if management cuts shipment or margin expectations, advanced-fab customers defer investment, or export controls materially restrict addressable demand. Reassess if EUV price increases are delayed, renegotiated, or fail to flow through to realized economics.
• Do not underwrite 2027–28 pricing as current-year earnings: seek confirmation from contract disclosures and subsequent margin guidance before assigning it material near-term value.